These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 5396500)

  • 1. BAY b 5097, a new orally applicable antifungal substance with broad-spectrum activity.
    Plempel M; Bartmann K; Büchel KH; Regel E
    Antimicrob Agents Chemother (Bethesda); 1969; 9():271-4. PubMed ID: 5396500
    [No Abstract]   [Full Text] [Related]  

  • 2. Clotrimazole (Lotrimin)--a new topical antifungal drug.
    Med Lett Drugs Ther; 1975 Sep; 17(19):77-8. PubMed ID: 1177811
    [No Abstract]   [Full Text] [Related]  

  • 3. Experimental study of a new orally effective broad-spectrum antimyocotic agent.
    Plempel M; Bartmann K; Büchel KH
    Ger Med Mon; 1969 Nov; 14(11):532-7. PubMed ID: 5392477
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on the activity of a new antimycotic (Bay b 5097) in children.
    Weingärtner L; Sitka U; Patsch R; Gründig C
    Int J Clin Pharmacol; 1972 Nov; 6(4):358-63. PubMed ID: 4641850
    [No Abstract]   [Full Text] [Related]  

  • 5. The activity in vitro and in vivo of a new imidazole antifungal, ketoconazole.
    Odds FC; Milne LJ; Gentles JC; Ball EH
    J Antimicrob Chemother; 1980 Jan; 6(1):97-104. PubMed ID: 6244258
    [No Abstract]   [Full Text] [Related]  

  • 6. [First experiences with the broad spectrum antimycotic BAY b 5097].
    Marget W; Adam D
    Med Klin; 1969 Jul; 64(27):1235-8. PubMed ID: 5799780
    [No Abstract]   [Full Text] [Related]  

  • 7. Bilogical and toxicological properties of econazole, a broad-spectrum antimycotic.
    Thienpont D; Van Cutsem J; Van Nueten JM; Niemegeers CJ; Marsboom R
    Arzneimittelforschung; 1975 Feb; 25(2):224-30. PubMed ID: 1173036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bay B 5097, a new orally applicable antifungal substance with broadspectrum activity. Preliminary clinical and laboratory experiences in children.
    Marget W; Adam D
    Acta Paediatr Scand; 1971 May; 60(3):341-5. PubMed ID: 5579860
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical experience with the systemic administration of clotrimazol. Pharmacokinetics, action, tolerance].
    Weuta H
    Arzneimittelforschung; 1974 Apr; 24(4):540-5. PubMed ID: 4408040
    [No Abstract]   [Full Text] [Related]  

  • 10. Miconazole, a broad-spectrum antimycotic agent with antibacterial activity.
    Van Cutsem JM; Thienpont D
    Chemotherapy; 1972; 17(6):392-404. PubMed ID: 4563141
    [No Abstract]   [Full Text] [Related]  

  • 11. [Electron microscopy studies on human pathogenic fungi. 1. Ultrastructural changes of Candida albicans cells due to clotrimazol in the animal experiment].
    Voigt WH; Plempel M
    Arzneimittelforschung; 1974 Apr; 24(4):508-15. PubMed ID: 4603515
    [No Abstract]   [Full Text] [Related]  

  • 12. Sertaconazole: updated review of a topical antifungal agent.
    Carrillo-Muñoz AJ; Giusiano G; Ezkurra PA; Quindós G
    Expert Rev Anti Infect Ther; 2005 Jun; 3(3):333-42. PubMed ID: 15954850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Miconazol nitrate, a new broad spectrum antimycotic for local therapy in dermatomycoses. II. Effect in trichophytosis, microsporia, and cutaneous candidiasis in guinea pigs].
    Refai M
    Mykosen; 1973 Feb; 16(2):67-8. PubMed ID: 4712323
    [No Abstract]   [Full Text] [Related]  

  • 14. Tioconazole, a new imidazole-antifungal agent for the treatment of dermatomycoses. Antifungal and pharmacologic properties.
    Marriott MS; Baird JR; Brammer KW; Faulkner JK; Halliwell G; Jevons S; Tarbit MH
    Dermatologica; 1983; 166 Suppl 1():1-7. PubMed ID: 6884559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antifungal compounds of Cynanchum vincetoxicum (L.) Pers. I. The quantitative antifungal spectrum of substance C-1.
    Ferenczy L; Zsolt J; Háznagy A; Tóth L; Szendrei K
    Acta Microbiol Acad Sci Hung; 1965-1966; 12(4):337-44. PubMed ID: 5895796
    [No Abstract]   [Full Text] [Related]  

  • 16. [Ketoconazole].
    Cuena Boy R; Azanza Perea JR; Honorato Pérez JM
    Rev Med Univ Navarra; 1982 Sep; 26(3):193-4. PubMed ID: 6302808
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pharmacokinetics of imidazole-antimycotics (author's transl)].
    Plempel M
    Mykosen; 1980 Jan; 23(1):16-27. PubMed ID: 7383054
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of Candida pyuria with the oral antigungal drug Bay b 5097 (author's transl)].
    Exss R; Azubuike JC
    Padiatr Padol; 1973; 8(4):433-5. PubMed ID: 4583282
    [No Abstract]   [Full Text] [Related]  

  • 19. [Antifungal resistance in opportunistic pathogenic fungi (II). Imidazoles and triazoles].
    Martínez-Suárez JV; Rodríguez-Tudela JL
    Enferm Infecc Microbiol Clin; 1996 Oct; 14(8):490-8. PubMed ID: 9011208
    [No Abstract]   [Full Text] [Related]  

  • 20. Apparent ketoconazole failure in candidal cholecystitis.
    Brooks BJ; Williams WL; Sanders CV; Marier RL
    Arch Intern Med; 1982 Oct; 142(10):1934-5. PubMed ID: 6289764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.